These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2951188)

  • 1. The course of incipient diabetic nephropathy.
    Tindall H; Hopper AH; Davies JA
    Diabet Med; 1986 May; 3(3):282-3. PubMed ID: 2951188
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
    Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
    Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers.
    Stornello M; Valvo EV; Scapellato L
    Clin Sci (Lond); 1992 Jan; 82(1):19-23. PubMed ID: 1310913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ACE inhibition on the course of nephropathy in type I diabetes mellitus.
    Meinders AE; Hes R; de Leeuw PW
    Neth J Med; 1992 Jun; 40(5-6):217-20. PubMed ID: 1436257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensives retarding progression of diabetic nephropathy.
    Hardy KJ
    Diabetologia; 1995 Jan; 38(1):123-4. PubMed ID: 7744219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Decrease of microalbuminuria caused by antihypertensive treatment in 10 diabetics with incipient diabetic nephropathy].
    Grimaldi A; Bosquet F; Coutarel P; Digy JP; Bordas M; Carayon A
    Ann Med Interne (Paris); 1987; 138(7):556-7. PubMed ID: 3439678
    [No Abstract]   [Full Text] [Related]  

  • 7. Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
    Andersen S; Jacobsen P; Tarnow L; Rossing P; Juhl TR; Parving HH
    Nephrol Dial Transplant; 2003 Feb; 18(2):293-7. PubMed ID: 12543883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
    Shestakova MV; Chugunova LA; Vorontsov AV; Dedov II
    Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A; Ribstein J; Mimran A
    Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-receptor blockers in the prevention or treatment of microalbuminuria.
    Parfrey PS
    Ann Intern Med; 2009 Jul; 151(1):63-5. PubMed ID: 19581647
    [No Abstract]   [Full Text] [Related]  

  • 14. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor.
    McGregor D; Bailey RR
    Nephron; 1997; 76(3):270-5. PubMed ID: 9226226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
    Mazerska M; Myśliwiec M
    Adv Med Sci; 2009; 54(1):37-40. PubMed ID: 19505872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indication of vitamin E on microalbuminuria in patients with incipient diabetic nephropathy.
    Yokoyama M; Torita M; Yoshizawa M; Usuda R
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):611-2. PubMed ID: 11694862
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
    Schnack C; Hoffmann W; Hopmeier P; Schernthaner G
    Diabetologia; 1996 Dec; 39(12):1611-6. PubMed ID: 8960851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finerenone for Albuminuria in Patients With Diabetic Nephropathy.
    Feng Y; Zeng X; Fu P
    JAMA; 2016 Jan; 315(3):305-6. PubMed ID: 26784783
    [No Abstract]   [Full Text] [Related]  

  • 19. Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
    Bakris GL; Nowack C
    JAMA; 2016 Jan; 315(3):306. PubMed ID: 26784785
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetic nephropathy: Nonsteroidal MRA added to RAS blockade reduces albuminuria.
    Weir MR
    Nat Rev Nephrol; 2015 Dec; 11(12):691-2. PubMed ID: 26460357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.